Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID‐19: A propensity score‐matched analysis-Reference-Cited by-同舟云学术

Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID‐19: A propensity score‐matched analysis

Published:2021-09-15 Issue:11 Volume:19 Page:2814-2824
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Chow Jonathan H.¹^ORCID,Yin Ying²,Yamane David P.¹³,Davison Danielle¹,Keneally Ryan J.¹,Hawkins Katrina¹,Parr K. Gage¹,Al‐Mashat Mustafa¹,Berger Jeffery S.¹,Bushardt Reamer L.²,Mazzeffi Michael A.¹,Nelson Stuart J.²

Affiliation:

1. Department of Anesthesiology and Critical Care Medicine George Washington University School of Medicine and Health Sciences Washington DC USA

2. George Washington University School of Medicine and Health Sciences Washington DC USA

3. Department of Emergency Medicine George Washington University School of Medicine and Health Sciences Washington DC USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15517

Reference37 articles.

1. World Health OrganizationCoronavirus disease (COVID‐19) outbreak.https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019. Published 2020. Accessed Sept 9 2021.

2. New York TimesTracking coronavirus vaccinations around the world.https://www.nytimes.com/interactive/2021/world/covid‐vaccinations‐tracker.html. Published 2021. Accessed Sept 9 2021.

3. Johns Hopkins UniversityCoronavirus Resource Center.https://coronavirus.jhu.edu/. Published 2021. Accessed Sept 9 2021.

4. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet dysfunction caused by differentially expressed genes as key pathogenic mechanisms in COVID-19;Minerva Cardiology and Angiology;2024-09

2. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management;Journal of Thrombosis and Thrombolysis;2024-08-23

3. Impacto del uso previo de antiagregantes plaquetarios en la susceptibilidad, la progresión y la gravedad de la COVID-19: un estudio poblacional;Revista Española de Cardiología;2024-07

4. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study;Revista Española de Cardiología (English Edition);2024-07

5. Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial;PLOS ONE;2024-06-17